Resources

STREAM is a multi-country clinical trial evaluating shorter, more tolerable multidrug-resistant tuberculosis (MDR-TB) regimens, carried out over more than 10 years. The trial offered an exceptional opportunity to evaluate key issues related to implementing clinical trials.

This study evaluated the impact of the COVID-19 pandemic on excess mortality by race/skin color in Brazil over the course of nine months in 2020. Excess mortality among black/brown populations was remarkably higher compared to the white population, being as high as 26.3%, and accounting for 58.9% of excess deaths.

This paper sets out a summary of the experiences of CABs in connection with the STREAM clinical trial. It underlines relevant aspects that may be useful when planning and/or engaging communities in research.

Um novo relatório da Vital Strategies, A verdade sóbria: Incentivando a morte e a deficiência por álcool, revela esses “incentivos perversos” e também examina como a indústria interfere nas políticas governamentais que visam reduzir o consumo de bebidas alcoólicas. O relatório propõe recomendações-chave para os países fortalecerem seus sistemas de saúde contra o uso prejudicial do álcool.

In 2021, Vital Strategies with partners in Indonesia conducted a household survey of 2,281 adolescents between age 13-15 years to determine the extent of exposure to tobacco marketing. This data brief presents key findings from the study.

This technical guide outlines the conceptual framework for population registers as the first document in a knowledge series being developed by the Pacific Community (SPC) and Vital Strategies with support from the Bloomberg Philanthropies Data for Health Initiative.